Evaluation by brain MRI of white matter perivenular lesions in inflammatory micro-angiopatic ischemia and in demyelinating multiple sclerosis lesions
2016 Massacesi, L
Intermediate intensity regimen in autologous HSCT for severe multiple sclerosis: a large, single center experience
2016 Saccardi, R; Repice, AM; Innocenti, C; Mariottini, A; Amato, MP; Guidi, S; Fani, A; Nistri, R; Giannini, M; Portaccio, E; Barilaro, A; Nozzoli, C; Gozzini, A; Massacesi, L
THIENO-TRIAZOLODIAZEPINES BLOCK HEPATOCARCINOMA PROGRESSION BY HSP-DEPENDENT KINOMA INHIBITION
2015 Ceni, E ; Tarocchi, M ; Polvani, S ; Malentacchi, C ; Marroncini, G ; Mello, T; Tempesti, S ; Galli, A
Severe disease reactivation in two multiple sclerosis patients after natalizumab withdrawal was not halted by monthly administrations of cyclophosphamide - two case reports
2017 Mariottini, A; Forci, B; Magnani, E; Massacesi, L; Repice, A
Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments
2017 Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Massacesi, L; Repice, A
Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience
2017 Boffa, G; Sormani, MP; Repice, AM; Curro, D; Capobianco, M; Gualandi, F; Lo Re, M; De Gobbi, M; Innocenti, C; Capello, E; Mariottini, A; Forci, B; Uccelli, A; Barilaro, A; Cottone, S; Bertolotto, A; Saccardi, R; Mancardi, GL; Massacesi, L
Autoimmune epilepsy in drug resistent and in new onset refractory epilepsy
2018 Pradella, S; Paganini, M; Barilaro, A; Casagrande, S; Biagioli, T; Franciotta, D; Massacesi, L
Soluble factor profile in Natalizumab treated MS patients: increased Th1 promoting factors and sHLAg
2018 Aldinucci, A; Rizzo, R; Bonechi, E; Fainardi, E; Bortolotti, D; Mariottini, A; Mechi, C; Repice, AM; Massacesi, L; Ballerini, C
Natural history of brain inflammatory lesions in multiple sclerosis: a FLAIR and T1w post contrast MRI volumetric analysis
2018 Maggi, P; Zellini, F; Passeri, A; Barilaro, A; Massacesi, L
Challenges for modern MS therapy on back-ground of pathogenesis
2018 Massacesi, L
Reconstitution of natural or vaccination-driven immunity after aHSCT in multiple sclerosis
2018 Innocenti, C; Amato, MP; Barilaro, A; Bianchini, G; Capobianco, T; Calia, MA; Ceschini, R; Fani, A; Giannini, M; Gozzini, A; Guidi, S; Mariottini, A; Massacesi, L; Nozzoli, C; Repice, A; Rossolini, G; Saccardi, R
Alemtuzumab outcomes over 6 years in RRMS patients who switched from SC IFNB-1a: follow-up of CARE-MS I patients (TOPAZ study)
2018 Van Wijmeersch, B; Barone, D; Broadley, S; Dive, D; Hupperts, RMM; Lycke, J; Massacesi, L; Montalban, X; Naismith, RT; Pandey, K; Schippling, S; Vermersch, P; Chung, L; Daizadeh, N; Rodriguez, CE; Nakamura, K; Wiendl, H
SIRT1 ACTIVATION PREVENTS APOPTOSIS AND SENESCENCE OF HEPATIC STELLATE CELL DURING LIVER INJURY
2015 Tarocchi, M ; Marroncini, G ; Ceni, E ; Polvani, S ; Tempesti, S ; Mello, T ; Milani, S ; Galli, A .
POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY: AN OBSERVATIONAL STUDY
2019 Mata, S; Barilaro, A; Massacesi, L; Sorbi, S
The spectrum of auto-immune encephalitis: Clinical characterisation and comparison between different syndromes defined by 2016 diagnostic criteria
2019 Casagrande, S; Gastaldi, M; Barilaro, A; Biagioli, T; Paganini, M; Franciotta, D; Massacesi, L
Alemtuzumab improves outcomes in RRMS patients who switched from SC IFNB-1a: 6-year follow-up of CARE-MS I Patients (TOPAZ Study)
2019 Montalban, X; Barone, D; Broadley, S; Dive, D; Hupperts, RM; Lycke, J; Massacesi, L; Naismith, RT; Nakamura, K; Pandey, K; Schippling, S; Vermersch, P; Wiendl, H; Chung, L; Daizadeh, N; Afsar, S; Van Wijmeersch, B
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments
2019 Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Falcini, M; Palumbo, P; Massacesi, L; Repice, AM
Ruvbl1 regulates liver glucose metabolism via the Akt/mTOR pathway: Implications for hepatocellular carcinoma progression
2016 Mello, T.; Zanieri, F.; Materozzi, M.; Bereshchenko, O.; Ceni, E.; Tarocchi, M.; Marroncini, G.; Polvani, S.; Tempesti, S.; Nerlov, C.; Milani, S.; Galli, A.
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation
2019 Mechi, C; Mariottini, A; Pasca, M; Forci, B; Magnani, E; Barilaro, A; Repice, AM; Massacesi, L
Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis
2019 Mariottini, A; Filippini, S; Di Tullio, MG; Forci, B; Innocenti, C; Barilaro, A; Fani, A; Saccardi, R; Massacesi, L; Repice, AM
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Evaluation by brain MRI of white matter perivenular lesions in inflammatory micro-angiopatic ischemia and in demyelinating multiple sclerosis lesions | 2016 | Massacesi, L | |
| Intermediate intensity regimen in autologous HSCT for severe multiple sclerosis: a large, single center experience | 2016 | Saccardi, R; Repice, AM; Innocenti, C; Mariottini, A; Amato, MP; Guidi, S; Fani, A; Nistri, R; Giannini, M; Portaccio, E; Barilaro, A; Nozzoli, C; Gozzini, A; Massacesi, L | |
| THIENO-TRIAZOLODIAZEPINES BLOCK HEPATOCARCINOMA PROGRESSION BY HSP-DEPENDENT KINOMA INHIBITION | 2015 | Ceni, E ; Tarocchi, M ; Polvani, S ; Malentacchi, C ; Marroncini, G ; Mello, T; Tempesti, S ; Galli, A | |
| Severe disease reactivation in two multiple sclerosis patients after natalizumab withdrawal was not halted by monthly administrations of cyclophosphamide - two case reports | 2017 | Mariottini, A; Forci, B; Magnani, E; Massacesi, L; Repice, A | |
| Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments | 2017 | Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Massacesi, L; Repice, A | |
| Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience | 2017 | Boffa, G; Sormani, MP; Repice, AM; Curro, D; Capobianco, M; Gualandi, F; Lo Re, M; De Gobbi, M; Innocenti, C; Capello, E; Mariottini, A; Forci, B; Uccelli, A; Barilaro, A; Cottone, S; Bertolotto, A; Saccardi, R; Mancardi, GL; Massacesi, L | |
| Autoimmune epilepsy in drug resistent and in new onset refractory epilepsy | 2018 | Pradella, S; Paganini, M; Barilaro, A; Casagrande, S; Biagioli, T; Franciotta, D; Massacesi, L | |
| Soluble factor profile in Natalizumab treated MS patients: increased Th1 promoting factors and sHLAg | 2018 | Aldinucci, A; Rizzo, R; Bonechi, E; Fainardi, E; Bortolotti, D; Mariottini, A; Mechi, C; Repice, AM; Massacesi, L; Ballerini, C | |
| Natural history of brain inflammatory lesions in multiple sclerosis: a FLAIR and T1w post contrast MRI volumetric analysis | 2018 | Maggi, P; Zellini, F; Passeri, A; Barilaro, A; Massacesi, L | |
| Challenges for modern MS therapy on back-ground of pathogenesis | 2018 | Massacesi, L | |
| Reconstitution of natural or vaccination-driven immunity after aHSCT in multiple sclerosis | 2018 | Innocenti, C; Amato, MP; Barilaro, A; Bianchini, G; Capobianco, T; Calia, MA; Ceschini, R; Fani, A; Giannini, M; Gozzini, A; Guidi, S; Mariottini, A; Massacesi, L; Nozzoli, C; Repice, A; Rossolini, G; Saccardi, R | |
| Alemtuzumab outcomes over 6 years in RRMS patients who switched from SC IFNB-1a: follow-up of CARE-MS I patients (TOPAZ study) | 2018 | Van Wijmeersch, B; Barone, D; Broadley, S; Dive, D; Hupperts, RMM; Lycke, J; Massacesi, L; Montalban, X; Naismith, RT; Pandey, K; Schippling, S; Vermersch, P; Chung, L; Daizadeh, N; Rodriguez, CE; Nakamura, K; Wiendl, H | |
| SIRT1 ACTIVATION PREVENTS APOPTOSIS AND SENESCENCE OF HEPATIC STELLATE CELL DURING LIVER INJURY | 2015 | Tarocchi, M ; Marroncini, G ; Ceni, E ; Polvani, S ; Tempesti, S ; Mello, T ; Milani, S ; Galli, A . | |
| POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY: AN OBSERVATIONAL STUDY | 2019 | Mata, S; Barilaro, A; Massacesi, L; Sorbi, S | |
| The spectrum of auto-immune encephalitis: Clinical characterisation and comparison between different syndromes defined by 2016 diagnostic criteria | 2019 | Casagrande, S; Gastaldi, M; Barilaro, A; Biagioli, T; Paganini, M; Franciotta, D; Massacesi, L | |
| Alemtuzumab improves outcomes in RRMS patients who switched from SC IFNB-1a: 6-year follow-up of CARE-MS I Patients (TOPAZ Study) | 2019 | Montalban, X; Barone, D; Broadley, S; Dive, D; Hupperts, RM; Lycke, J; Massacesi, L; Naismith, RT; Nakamura, K; Pandey, K; Schippling, S; Vermersch, P; Wiendl, H; Chung, L; Daizadeh, N; Afsar, S; Van Wijmeersch, B | |
| Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments | 2019 | Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Falcini, M; Palumbo, P; Massacesi, L; Repice, AM | |
| Ruvbl1 regulates liver glucose metabolism via the Akt/mTOR pathway: Implications for hepatocellular carcinoma progression | 2016 | Mello, T.; Zanieri, F.; Materozzi, M.; Bereshchenko, O.; Ceni, E.; Tarocchi, M.; Marroncini, G.; Polvani, S.; Tempesti, S.; Nerlov, C.; Milani, S.; Galli, A. | |
| Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation | 2019 | Mechi, C; Mariottini, A; Pasca, M; Forci, B; Magnani, E; Barilaro, A; Repice, AM; Massacesi, L | |
| Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis | 2019 | Mariottini, A; Filippini, S; Di Tullio, MG; Forci, B; Innocenti, C; Barilaro, A; Fani, A; Saccardi, R; Massacesi, L; Repice, AM |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 - Contributo su rivista4448
- 4 - Contributo in atti di convegno (Proceedings)1
Data di pubblicazione
- In corso di stampa1
- 2020 - 2026395
- 2010 - 20192059
- 2000 - 20091389
- 1990 - 1999501
- 1980 - 198999
- 1975 - 19794
Editore
- EGU General Assembly 20201
- ELSEVIER SCIENCE INC1
- European Association for the Study of the Liver1
- Italian Pharmacol Soc; Dutch Pharmacol Soc1
- SPRINGER1
Rivista
- ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY182
- EUROPEAN UROLOGY. SUPPLEMENTS173
- EUROPEAN HEART JOURNAL136
- GEOPHYSICAL RESEARCH ABSTRACTS122
- JOURNAL OF PEPTIDE SCIENCE92
- ANNALS OF THE RHEUMATIC DISEASES74
- THE JOURNAL OF UROLOGY71
- JOURNAL OF HEPATOLOGY67
- CIRCULATION61
- JOURNAL OF PLANT PATHOLOGY61
Keyword
- partial nephrectomy47
- renal cell carcinoma46
- Multiple Sclerosis29
- landslide28
- systemic sclerosis26
- cellule dendritiche25
- multiple sclerosis25
- medical physics24
- pharmacology23
- peptide21
Lingua
- eng2701
- ita153
- fre5
- por1
- spa1
Accesso al fulltext
- no fulltext3214
- reserved711
- open518
- partially open5